134
Participants
Start Date
March 31, 2004
Primary Completion Date
July 31, 2009
Study Completion Date
July 31, 2009
Bupropion SR
Bupropion SR, with goal dose 300 mg/day, for 6 weeks of active treatment
Contingency Management
Contingency Management provided at twice-weekly visits during the 6-week active treatment. Escalating schedule, with resets, reinforcing smoking abstinence.
Placebo
Placebo, matched in appearance to Bupropion SR, for 6 weeks of treatment
Medical University of South Carolina, Charleston
National Institute on Drug Abuse (NIDA)
NIH
Medical University of South Carolina
OTHER